Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FlowMetric Diagnostics is a specialized contract research organization (CRO) and diagnostic laboratory that provides high-dimensional flow cytometry and cellular analysis services. The company supports the life sciences industry through all stages of drug development, from preclinical research to global clinical trials, with a focus on immune monitoring and biomarker discovery. Their services include assay development, validation, and clinical sample processing for therapeutic areas such as oncology, immunology, and infectious diseases. Following its acquisition by KCAS Bioanalytical and Biomarker Services in 2022, FlowMetric continues to offer advanced flow cytometry solutions as part of a broader bioanalytical service portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FlowMetric Diagnostics.